Literature DB >> 29217758

Targeting Myocardial Energetics in the Failing Heart: Are We There Yet?

Douglas L Mann1.   

Abstract

Entities:  

Keywords:  Editorials; adenosine monophosphate; heart failure; mitochondria, heart; reactive oxygen species

Mesh：

Substances：

Year:  2017        PMID： 29217758      PMCID： PMC5728660          DOI： 10.1161/CIRCHEARTFAILURE.117.004658

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN： 1941-3289            Impact factor:   8.790


× No keyword cloud information.
  11 in total

Review 1.  The failing heart--an engine out of fuel.

Authors:  Stefan Neubauer
Journal:  N Engl J Med       Date:  2007-03-15       Impact factor: 91.245

Review 2.  Cardiac metabolism in heart failure: implications beyond ATP production.

Authors:  Torsten Doenst; Tien Dung Nguyen; E Dale Abel
Journal:  Circ Res       Date:  2013-08-30       Impact factor: 17.367

Review 3.  Therapies for mitochondrial diseases and current clinical trials.

Authors:  Ayman W El-Hattab; Ana Maria Zarante; Mohammed Almannai; Fernando Scaglia
Journal:  Mol Genet Metab       Date:  2017-09-18       Impact factor: 4.797

4.  Novel Mitochondria-Targeting Peptide in Heart Failure Treatment: A Randomized, Placebo-Controlled Trial of Elamipretide.

Authors:  Melissa A Daubert; Eric Yow; Gary Dunn; Sotir Marchev; Huiman Barnhart; Pamela S Douglas; Christopher O'Connor; Sidney Goldstein; James E Udelson; Hani N Sabbah
Journal:  Circ Heart Fail       Date:  2017-12       Impact factor: 8.790

5.  A highly potent peptide analgesic that protects against ischemia-reperfusion-induced myocardial stunning.

Authors:  Dunli Wu; Yi Soong; Guo-Min Zhao; Hazel H Szeto
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-08       Impact factor: 4.733

Review 6.  Mitochondrial Function, Biology, and Role in Disease: A Scientific Statement From the American Heart Association.

Authors:  Elizabeth Murphy; Hossein Ardehali; Robert S Balaban; Fabio DiLisa; Gerald W Dorn; Richard N Kitsis; Kinya Otsu; Peipei Ping; Rosario Rizzuto; Michael N Sack; Douglas Wallace; Richard J Youle
Journal:  Circ Res       Date:  2016-04-28       Impact factor: 17.367

Review 7.  Mitochondria-targeted disruptors and inhibitors of cytochrome c/cardiolipin peroxidase complexes: a new strategy in anti-apoptotic drug discovery.

Authors:  Valerian E Kagan; Ayse Bayir; Hulya Bayir; Detcho Stoyanovsky; Grigory G Borisenko; Yulia Y Tyurina; Peter Wipf; Jeffrey Atkinson; Joel S Greenberger; Robert S Chapkin; Natalia A Belikova
Journal:  Mol Nutr Food Res       Date:  2009-01       Impact factor: 5.914

8.  Potent mitochondria-targeted peptides reduce myocardial infarction in rats.

Authors:  Janghyun Cho; Kyungheon Won; DunLi Wu; Yi Soong; Shaoyi Liu; Hazel H Szeto; Mun K Hong
Journal:  Coron Artery Dis       Date:  2007-05       Impact factor: 1.439

9.  Chronic Therapy With Elamipretide (MTP-131), a Novel Mitochondria-Targeting Peptide, Improves Left Ventricular and Mitochondrial Function in Dogs With Advanced Heart Failure.

Authors:  Hani N Sabbah; Ramesh C Gupta; Smita Kohli; Mengjun Wang; Souheila Hachem; Kefei Zhang
Journal:  Circ Heart Fail       Date:  2016-02       Impact factor: 8.790

10.  Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury.

Authors:  Victoria J Adlam; Joanne C Harrison; Carolyn M Porteous; Andrew M James; Robin A J Smith; Michael P Murphy; Ivan A Sammut
Journal:  FASEB J       Date:  2005-07       Impact factor: 5.191
View more
  9 in total

Review 1.  Myocardial Energetics and Heart Failure: a Review of Recent Therapeutic Trials.

Authors:  Kunal N Bhatt; Javed Butler
Journal:  Curr Heart Fail Rep       Date:  2018-06

Review 2.  Obesity, Hypertension, and Cardiac Dysfunction: Novel Roles of Immunometabolism in Macrophage Activation and Inflammation.

Authors:  Alan J Mouton; Xuan Li; Michael E Hall; John E Hall
Journal:  Circ Res       Date:  2020-03-12       Impact factor: 17.367

Review 3.  Novel roles of immunometabolism and nonmyocyte metabolism in cardiac remodeling and injury.

Authors:  Alan J Mouton; John E Hall
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2020-09-02       Impact factor: 3.619

4.  Molecular Mechanism of the Association Between Atrial Fibrillation and Heart Failure Includes Energy Metabolic Dysregulation Due to Mitochondrial Dysfunction.

Authors:  Cevher Ozcan; Zhenping Li; Gene Kim; Valluvan Jeevanandam; Nir Uriel
Journal:  J Card Fail       Date:  2019-08-12       Impact factor: 5.712

5.  Targeting Mitochondrial Function in Heart Failure: Makes Sense But Will it Work?

Authors:  Muhammad Shahzeb Khan; Javed Butler
Journal:  JACC Basic Transl Sci       Date:  2019-04-29

6.  Elamipretide Improves Mitochondrial Function in the Failing Human Heart.

Authors:  Kathryn C Chatfield; Genevieve C Sparagna; Sarah Chau; Elisabeth K Phillips; Amrut V Ambardekar; Muhammad Aftab; Max B Mitchell; Carmen C Sucharov; Shelley D Miyamoto; Brian L Stauffer
Journal:  JACC Basic Transl Sci       Date:  2019-04-29

Review 7.  Human pluripotent stem cell-derived cardiomyocytes for studying energy metabolism.

Authors:  Bärbel M Ulmer; Thomas Eschenhagen
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2019-04-04       Impact factor: 4.739

Review 8.  Recently Approved and Under Investigation Drugs for Treating Patients with Heart Failure.

Authors:  Yaniel Castro-Torres; Richard E Katholi
Journal:  Curr Cardiol Rev       Date:  2020

9.  Impact of Myocardial Energy Expenditure and Diastolic Dysfunction on One Year Outcome Patients With HFpEF.

Authors:  Yu Wang; Yalan Cao; Shuting Xiang; Shunji Liang; Xiumei Yang; Ning Zhu; Weiyi Fang; Qin Yu
Journal:  Front Physiol       Date:  2022-04-04       Impact factor: 4.755
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.